-
Cefepime (BMY-28142) in Multidrug-Resistant Infection Resear
2026-07-06
Explore the scientific foundation and advanced research applications of Cefepime (BMY-28142) as a broad-spectrum cephalosporin antibiotic. This article uniquely analyzes its role in modeling multidrug-resistant infections, integrating new insights from recent resistance studies.
-
HyperFusion High-Fidelity DNA Polymerase in Neurogenetics PC
2026-07-06
HyperFusion™ high-fidelity DNA polymerase enables robust, precise amplification of even the most challenging templates, streamlining complex neurogenetics workflows. Its fusion design, proven in high-throughput and GC-rich PCR, delivers unmatched fidelity for applications like cloning and sequencing.
-
Clodronate Liposomes: Optimizing In Vivo Macrophage Depletio
2026-07-05
Clodronate Liposomes empower researchers to precisely deplete macrophages in vivo, unraveling immune cell functions in disease models. This guide details optimized workflows, advanced applications, and troubleshooting strategies that maximize experimental impact—especially for dissecting tumor resistance mechanisms.
-
Artesunate in Cancer Research: Workflows, Mechanisms & Solut
2026-07-04
Artesunate, an advanced artemisinin derivative, stands out for its dual action as an AKT/mTOR signaling inhibitor and potent ferroptosis inducer in cancer models. This article delivers actionable workflows, troubleshooting strategies, and practical guidance for maximizing Artesunate's research value, especially in small cell lung carcinoma and esophageal squamous cell carcinoma studies.
-
Oseltamivir Acid: Influenza Neuraminidase Inhibitor Factshee
2026-07-03
Oseltamivir acid is a potent influenza neuraminidase inhibitor that blocks viral sialidase activity to prevent influenza virus release. It demonstrates robust solubility and efficacy in both virology and oncology research and is subject to resistance via H275Y mutation. This dossier summarizes its mechanism, benchmarks, and workflow integration.
-
Simvastatin (Zocor): Workflow Innovations in Cancer & Choles
2026-07-03
Simvastatin (Zocor) from APExBIO empowers researchers pursuing both cancer biology and lipid metabolism with protocol-driven precision and robust reproducibility. Explore actionable workflows, troubleshooting insights, and novel findings that position Simvastatin as a go-to tool for apoptosis and autophagy research in hepatic and prostate cancer models.
-
PreScission Protease (PSP): Workflow Parameters and Best Use
2026-07-02
PreScission Protease (PSP) addresses the need for precise and efficient fusion tag removal in protein purification workflows, particularly for applications requiring low temperature activity to preserve protein structure. It should be used when high specificity at the Gln-Gly bond is critical, but may be less suitable for targets lacking the required cleavage site or those sensitive to GST fusion presence.
-
CCL7+ Macrophages Drive Immunotherapy Resistance in CRC
2026-07-02
This study uncovers how CCL7-expressing tumor-associated macrophages (TAMs) mediate immune checkpoint inhibitor resistance in colorectal cancer by modulating immune cell infiltration and metabolic function. The results highlight CCL7 as a promising target to enhance immunotherapy efficacy and suggest new strategies for macrophage-targeted interventions.
-
SM-164: Redefining Apoptosis Induction in Translational Onco
2026-07-01
This thought-leadership article explores how SM-164, a bivalent Smac mimetic, is empowering researchers to dissect and modulate apoptosis in tumor models with unprecedented specificity. By integrating recent mechanistic insights and translational strategies, it guides oncology researchers in leveraging SM-164 to bridge the gap between in vitro signaling studies and in vivo therapeutic innovation, while critically appraising emerging evidence on cell death pathways, including Pol II degradation.
-
Ferrostatins Block Oxidative Lipid Damage Across Disease Mod
2026-07-01
This study demonstrates that ferrostatins, particularly ferrostatin-1, inhibit ferroptosis by preventing lipid peroxidation in diverse cellular models of disease, including neurodegeneration and kidney dysfunction. The research provides mechanistic clarity on ferrostatin action and highlights lipid peroxidation as a central driver of cell death in these contexts, guiding antioxidant assay development and translational research.
-
AS1842856 Foxo1 Inhibitor: Transforming Metabolic Research W
2026-06-30
AS1842856 is redefining metabolic and stem cell research by enabling precise, robust inhibition of Foxo1-mediated pathways. This article details practical workflows, advanced applications, and troubleshooting strategies that unlock the full power of this high-purity Foxo1 inhibitor.
-
Lenalidomide (CC-5013): Next-Gen Immunomodulation in Myeloma
2026-06-30
This thought-leadership article explores how Lenalidomide (CC-5013) is transforming multiple myeloma research through its multimodal mechanisms—immunomodulation, angiogenesis inhibition, and epigenetic synergy. By integrating emerging evidence on DOT1L inhibition, the article provides actionable guidance for translational researchers seeking to optimize experimental models and combination strategies, while elevating the conversation beyond traditional product summaries.
-
Phenytoin and Other AEDs Inhibit Serum Paraoxonase-1 Activit
2026-06-29
This study systematically evaluates the in vitro inhibitory effects of several antiepileptic drugs—including phenytoin—on purified human serum paraoxonase-1 (hPON1) activity. The findings reveal that all tested AEDs act as noncompetitive inhibitors of hPON1, with distinct potency profiles, highlighting potential metabolic and cardiovascular considerations in epilepsy therapy.
-
Intravesical p21 mRNA-LNP for Bladder Cancer: Mechanistic Ad
2026-06-29
This study establishes intravesical delivery of p21 mRNA-loaded lipid nanoparticles (LNPs) as an effective tumor suppressor replacement therapy for bladder cancer, demonstrating robust local protein expression and tumor inhibition. The findings point to a translational pathway for mRNA-based localized therapies in oncology, leveraging precise molecular design and delivery.
-
Lipid Scrambling Regulates Ferroptosis and Tumor Immune Reje
2026-06-28
Yang et al. (2025) identify TMEM16F-mediated lipid scrambling as a suppressor of ferroptosis, revealing how plasma membrane phospholipid dynamics modulate cell death and tumor immunity. Their work uncovers new mechanistic links between membrane remodeling and immune-mediated tumor rejection, with significant translational implications for cancer therapy.